Is BrightSpring Health Stock a Good Investment?
BrightSpring Health Investment Advice | BTSGU |
- Examine BrightSpring Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research BrightSpring Health's leadership team and their track record. Good management can help BrightSpring Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Healthcare space and any emerging trends that could impact BrightSpring Health's business and its evolving consumer preferences.
- Compare BrightSpring Health's performance and market position to its competitors. Analyze how BrightSpring Health is positioned in terms of product offerings, innovation, and market share.
- Check if BrightSpring Health pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about BrightSpring Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in BrightSpring Health Services, stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if BrightSpring Health Services, is a good investment.
Sell | Buy |
Strong Buy
Market Performance | Solid | Details | |
Volatility | Very steady | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine BrightSpring Health Stock
Researching BrightSpring Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company last dividend was issued on the 1st of August 2024.
To determine if BrightSpring Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding BrightSpring Health's research are outlined below:
The company reported the revenue of 8.83 B. Net Loss for the year was (154.6 M) with profit before overhead, payroll, taxes, and interest of 0. | |
On 1st of November 2024 BrightSpring Health paid 0.8438 per share dividend to its current shareholders | |
Latest headline from thelincolnianonline.com: Walleye Capital LLC Sells 100,000 Shares of BrightSpring Health Services, Inc. |
BrightSpring Health Quarterly Cost Of Revenue |
|
BrightSpring Health's profitablity analysis
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.08) | (0.07) | |
Return On Capital Employed | 0.03 | 0.06 | |
Return On Assets | (0.03) | (0.03) | |
Return On Equity | (0.26) | (0.25) |
Determining BrightSpring Health's profitability involves analyzing its financial statements and using various financial metrics to determine if BrightSpring Health is a good buy. For example, gross profit margin measures BrightSpring Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of BrightSpring Health's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in BrightSpring Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BrightSpring Health Services,. Check BrightSpring Health's Beneish M Score to see the likelihood of BrightSpring Health's management manipulating its earnings.
Evaluate BrightSpring Health's management efficiency
Return On Capital Employed is likely to gain to 0.06 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (0.07). Non Current Liabilities Other is likely to gain to about 22.1 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 1 B in 2024. BrightSpring Health's management efficiency ratios could be used to measure how well BrightSpring Health manages its routine affairs as well as how well it operates its assets and liabilities.Last Reported | Projected for Next Year | ||
Book Value Per Share | 3.58 | 3.40 | |
Tangible Book Value Per Share | (16.81) | (17.65) | |
Enterprise Value Over EBITDA | 15.85 | 9.04 | |
Price Book Value Ratio | 3.22 | 3.38 | |
Enterprise Value Multiple | 15.85 | 9.04 | |
Price Fair Value | 3.22 | 3.38 |
At BrightSpring Health, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Dividend Yield 0.0244 | Forward Dividend Yield 0.0244 |
Basic technical analysis of BrightSpring Stock
As of the 1st of December, BrightSpring Health shows the Mean Deviation of 1.7, risk adjusted performance of 0.2049, and Downside Deviation of 1.63. BrightSpring Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Understand BrightSpring Health's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing BrightSpring Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
Risk Adjusted Performance | 0.2049 | |||
Market Risk Adjusted Performance | 0.5512 | |||
Mean Deviation | 1.7 | |||
Semi Deviation | 1.18 | |||
Downside Deviation | 1.63 | |||
Coefficient Of Variation | 385.71 | |||
Standard Deviation | 2.34 | |||
Variance | 5.47 | |||
Information Ratio | 0.2004 | |||
Jensen Alpha | 0.4556 | |||
Total Risk Alpha | 0.2059 | |||
Sortino Ratio | 0.288 | |||
Treynor Ratio | 0.5412 | |||
Maximum Drawdown | 15.06 | |||
Value At Risk | (1.97) | |||
Potential Upside | 3.55 | |||
Downside Variance | 2.65 | |||
Semi Variance | 1.4 | |||
Expected Short fall | (2.22) | |||
Skewness | 1.78 | |||
Kurtosis | 7.69 |
Risk Adjusted Performance | 0.2049 | |||
Market Risk Adjusted Performance | 0.5512 | |||
Mean Deviation | 1.7 | |||
Semi Deviation | 1.18 | |||
Downside Deviation | 1.63 | |||
Coefficient Of Variation | 385.71 | |||
Standard Deviation | 2.34 | |||
Variance | 5.47 | |||
Information Ratio | 0.2004 | |||
Jensen Alpha | 0.4556 | |||
Total Risk Alpha | 0.2059 | |||
Sortino Ratio | 0.288 | |||
Treynor Ratio | 0.5412 | |||
Maximum Drawdown | 15.06 | |||
Value At Risk | (1.97) | |||
Potential Upside | 3.55 | |||
Downside Variance | 2.65 | |||
Semi Variance | 1.4 | |||
Expected Short fall | (2.22) | |||
Skewness | 1.78 | |||
Kurtosis | 7.69 |
Consider BrightSpring Health's intraday indicators
BrightSpring Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BrightSpring Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
BrightSpring Health Corporate Filings
8K | 15th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 29th of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 18th of September 2024 The schedule filed by any person or group who acquires beneficial ownership of more than 5% of a voting class of a company's equity securities registered under Section 12 of the Act | ViewVerify |
BrightSpring Stock media impact
Far too much social signal, news, headlines, and media speculation about BrightSpring Health that are available to investors today. That information is available publicly through BrightSpring media outlets and privately through word of mouth or via BrightSpring internal channels. However, regardless of the origin, that massive amount of BrightSpring data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of BrightSpring Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of BrightSpring Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to BrightSpring Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive BrightSpring Health alpha.
BrightSpring Health Corporate Management
Steven Esq | Corporate Officer | Profile | |
Lisa Nalley | Chief Resources | Profile | |
BSN CHCE | Chief Officer | Profile | |
Phani Konduru | Chief Officer | Profile |
Additional Tools for BrightSpring Stock Analysis
When running BrightSpring Health's price analysis, check to measure BrightSpring Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrightSpring Health is operating at the current time. Most of BrightSpring Health's value examination focuses on studying past and present price action to predict the probability of BrightSpring Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrightSpring Health's price. Additionally, you may evaluate how the addition of BrightSpring Health to your portfolios can decrease your overall portfolio volatility.